Skip to Content
Merck
CN

752967

Phenyltriethylammonium iodide

97%, solid

Synonym(s):

Triethylphenylammonium iodide

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C12H20IN
CAS Number:
1010-19-1
Molecular Weight:
305.20
NACRES:
NA.22
PubChem Substance ID:
329766328
UNSPSC Code:
12352116
EC Number:
213-774-1
MDL number:
MFCD00050224

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Phenyltriethylammonium iodide, 97%

InChI key

WMSWXWGJYOIACA-UHFFFAOYSA-M

InChI

1S/C12H20N.HI/c1-4-13(5-2,6-3)12-10-8-7-9-11-12;/h7-11H,4-6H2,1-3H3;1H/q+1;/p-1

SMILES string

[I-].CC[N+](CC)(CC)c1ccccc1

assay

97%

form

solid

mp

127-133 °C

pictograms

Skull and crossbones
GHS06

signalword

Danger

Hazard Classifications

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCT1448
MKCR5117
MKCS6565
MKCM8910
MKCM8909

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

G L Zhang et al.
Yao xue xue bao = Acta pharmaceutica Sinica, 25(8), 604-607 (1990-01-01)
Six ingredients were isolated from the whole plant of Dactylicapnos torulosa (Hook. f. et Thomas.) Hutchins. Four of them were identified by UV, IR, 1HNMR and 13CNMR. One of them is a new compound named zijinlongine(I). The three others are
Neal Whitaker et al.
Journal of pharmaceutical sciences, 106(11), 3230-3241 (2017-07-03)
High protein concentration formulations are required for low-volume administration of therapeutic antibodies targeted for subcutaneous, self-administration by patients. Ultra-high concentrations (≥150 mg/mL) can lead to dramatically increased solution viscosities, which in turn can lead to stability, manufacturing, and delivery challenges. In

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service